ask="60.00"
ask_size="100"
average_daily_volume="396458"
bid="40.00"
bid_size="100"
book_value="14.23"
change="-0.11"
change_from_200_day_moving_average="-8.32"
change_from_50_day_moving_average="-3.82"
change_from_52_week_high="-19.62"
change_From_52_week_low="10.17"
change_in_percent="-0.27%"
close="41.36"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.44"
ebitda="-97.47M"
eps_estimate_current_year="-4.47"
eps_estimate_next_quarter="-1.18"
eps_estimate_next_year="-3.84"
ex_dividend_date="N/A"
float_shares="24516000"
high="42.89"
high_52_weeks="60.98"
last_trade_date="3/9/2017"
last_trade_price="41.36"
last_trade_size="16858"
last_trade_time="4:00pm"
low="40.67"
low_52_weeks="31.19"
market_capitalization="1.14B"
moving_average_200_day="49.68"
moving_average_50_day="45.18"
name="Five Prime Therapeutics
Inc."
notes="N/A"
one_year_target_price="65.29"
open="41.15"
pe_ratio="N/A"
peg_ratio="0.16"
percent_change_from_200_day_moving_average="-16.75%"
percent_change_from_50_day_moving_average="-8.46%"
percent_change_from_52_week_high="-32.17%"
percent_change_from_52_week_low="+32.61%"
previous_close="41.47"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.91"
price_per_sales="37.17"
revenue="30.69M"
shares_outstanding="27509000"
short_ratio="8.04"
stock_exchange="NMS"
symbol="FPRX"
volume="471109"
weeks_range_52="31.19 - 60.98"
